Cargando…
AT-rich interactive domain1A determines sensitivity to oxaliplatin in gastric cancer cells
BACKGROUND: Gastric cancer is a highly heterogeneous disease and its traditional histopathological classification is difficult to meet clinical needs. Oxaliplatin is an antitumor drug with high efficiency and low toxicity. Therefore, the insensitivity or secondary drug resistance of oxaliplatin to g...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798539/ https://www.ncbi.nlm.nih.gov/pubmed/35117354 http://dx.doi.org/10.21037/tcr-20-2384 |